Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HYAL1 |
| Upstream (Parents) |
|---|
| (<<) AQP3 → HYAL1 |
| (<<) BDH1 → HYAL1 |
| (<<) CBS → HYAL1 |
| (<<) CYP4F2 → HYAL1 |
| (<<) GOT1 → HYAL1 |
| (<<) HSD11B1 → HYAL1 |
| (<<) HSD17B2 → HYAL1 |
| (<<) MT1F → HYAL1 |
| (<<) MT1G → HYAL1 |
| (<<) MT1P2 → HYAL1 |
| (<<) NNMT → HYAL1 |
| (<<) ORM1 → HYAL1 |
| (<<) PCK2 → HYAL1 |
| (<<) RDH16 → HYAL1 |
| (<<) SAA4 → HYAL1 |
| (<<) SOD1 → HYAL1 |
| Downstream (Children) |
|---|
| HYAL1 → CASP3 (>>) |
| HYAL1 → CD4 (>>) |
| HYAL1 → CDR2 (>>) |
| HYAL1 → CEBPD (>>) |
| HYAL1 → CSNK1D (>>) |
| HYAL1 → CXCL2 (>>) |
| HYAL1 → ELF4 (>>) |
| HYAL1 → ENO3 (>>) |
| HYAL1 → FGFR2 (>>) |
| HYAL1 → GNE (>>) |
| HYAL1 → HADH (>>) |
| HYAL1 → HGS (>>) |
| HYAL1 → IER2 (>>) |
| HYAL1 → ITGA2 (>>) |
| HYAL1 → MAP2K1 (>>) |
| HYAL1 → MLXIPL (>>) |
| HYAL1 → MMP7 (>>) |
| HYAL1 → MPHOSPH6 (>>) |
| HYAL1 → MTSS1 (>>) |
| HYAL1 → NFAT5 (>>) |
| HYAL1 → PHGDH (>>) |
| HYAL1 → PNPLA3 (>>) |
| HYAL1 → PRKCD (>>) |
| HYAL1 → PROCR (>>) |
| HYAL1 → PSAT1 (>>) |
| HYAL1 → PTK7 (>>) |
| HYAL1 → RAC1 (>>) |
| HYAL1 → RBKS (>>) |
| HYAL1 → RNASE4 (>>) |
| HYAL1 → SMO (>>) |
| HYAL1 → SMURF2 (>>) |
| HYAL1 → ST3GAL1 (>>) |
| HYAL1 → ST3GAL6 (>>) |
| HYAL1 → TFPI2 (>>) |
| HYAL1 → UGDH (>>) |
| HYAL1 → YWHAB (>>) |
